TP53 mutations are known to be the most common genetic mutations in cancer, and patients with a high rate of P53 mutations have stronger tumor aggressiveness and poorer prognosis, especially in patients with HCC, which is consistent with our findings. The gene discussed is TP53; the disease is hepatocellular carcinoma.